A young British woman has become one of the first cancer patients to be injected with a new vaccine designed to stimulate the immune system so that it destroys tumours wherever they have spread in the body. Kelly Potter, 35, was diagnosed with advanced cervical cancer in July 2015 and was among the first to be enrolled on a cancer vaccine trial that will run over the next two years involving up to 30 volunteers.
